Literature DB >> 14006195

Assay for 4-amino folic acid analogues by inhibition of folic acid reductase.

W C WERKHEISER, S F ZAKRZEWSKI, C A NICHOL.   

Abstract

Entities:  

Keywords:  DEHYDROGENASES/antagonists; FOLIC ACID ANTAGONISTS/chemistry

Mesh:

Substances:

Year:  1962        PMID: 14006195

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  9 in total

1.  Reappearance of dihydrofolate reductase in rodent tissues following methotrexate administration.

Authors:  D H Ho; W C Werkheiser
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

2.  A histochemical method for dihydrofolate reductase.

Authors:  D Onicescu; L Taşcă; E Trutza
Journal:  Histochem J       Date:  1970-07

3.  [Effect and istribution of methotrexate in the human organism during leukemia treatment].

Authors:  W Wilmanns; H Martin
Journal:  Klin Wochenschr       Date:  1968-03-15

4.  [Dihydrofolate reductase and thymidine kinase in the bone marrow under the influence of folic acid antagonists].

Authors:  W Wilmanns
Journal:  Klin Wochenschr       Date:  1967-10-01

5.  Affinity chromatography of dihydrofolate reductase.

Authors:  P C Newbold; N G Harding
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

6.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

7.  Central nervous system pharmacology of Baker's antifolate (NSC139105) in man.

Authors:  D J Stewart; M Leavens; K Lu; Y M Wang; R S Benjamin; D H Ho; H Y Yap; T L Loo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

8.  Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Klin Wochenschr       Date:  1983-11-02

9.  Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.